Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.ASO vs. AS: Which Stock Is the Better Value Option?
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
Amer Sports Chief Strategy Officer Exercises Options to Acquire More than $7 Million Shares. Is This a Signal to Buy AS?
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
Financial Comparison: Lakeland Industries (NASDAQ:LAKE) & Amer Sports (NYSE:AS)
Amer Sports, Inc. (AS) Analyst/Investor Day Transcript
Amer Sports' 2026 Outlook: Margin Expansion Drives Growth as Direct-to-Consumer Model Scales
Amer Sports: Best-In-Class With Undeniable Momentum
Amer Sports Updates Long-Term Financial Algorithm and Third Quarter 2026 Guidance
This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Lululemon's Problems May Not Be a Warning for Every Athleticwear Stock
Amer Sports: Fashion Risk Remains Despite Great Q2 Report
These Analysts Revise Their Forecasts On Amer Sports Following Q2 Results
Amer Sports, Inc. (AS) Q2 2026 Earnings Call Transcript
Amer Sports, Inc. (AS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Amer Sports Q2 Earnings Call Highlights
Amer Sports, Inc. (AS) Beats Q2 Earnings and Revenue Estimates
Amer Sports Reports Second Quarter 2026 Financial Results, Raises Full Year Revenue, Margin, and EPS Guidance
Already premium?